Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Immunization using autologous dendritic cells pulsed with the melanoma-associated antigen gp100-derived G280-9V peptide elicits CD8+ immunity
Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer
Medullary thyroid carcinoma: autologous tumor cell lines for dendritic cell vaccination
Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection
Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells
Intratumoral injection of dendritic cells transduced by an SV40-based vector expressing interleukin-15 induces curative immunity mediated by CD8+ T lymphocytes and NK cells
Phase I/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme
Dendritic cell-based cancer immunotherapy targeting MUC-1
Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions
Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells
Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
Natural killer cells in hepatitis C virus infection: from innate immunity to adaptive immunity
Natural killer-dendritic cell cross-talk in cancer immunotherapy
Administration of dendritic cells in cancer nodules in hepatocellular carcinoma
[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin’s lymphoma
The immunotherapy of prostate and bladder cancer